27.62 USD
-0.05 (-0.18%)
At close: Feb 11, 2026
27.62 USD
0 (0%)
After Hours: 2/11/2026, 8:00:01 PM
We assign a fundamental rating of 6 out of 10 to TCMD. TCMD was compared to 186 industry peers in the Health Care Equipment & Supplies industry. While TCMD has a great health rating, its profitability is only average at the moment. TCMD is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make TCMD suitable for growth investing!
1. Profitability
1.1 Basic Checks
- TCMD had positive earnings in the past year.
- TCMD had a positive operating cash flow in the past year.
- In multiple years TCMD reported negative net income over the last 5 years.
- In the past 5 years TCMD always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of TCMD (7.01%) is better than 88.17% of its industry peers.
- The Return On Equity of TCMD (8.86%) is better than 82.80% of its industry peers.
- The Return On Invested Capital of TCMD (7.56%) is better than 82.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.01% | ||
| ROE | 8.86% | ||
| ROIC | 7.56% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- TCMD's Profit Margin of 5.83% is fine compared to the rest of the industry. TCMD outperforms 79.03% of its industry peers.
- In the last couple of years the Profit Margin of TCMD has remained more or less at the same level.
- TCMD has a better Operating Margin (7.39%) than 73.66% of its industry peers.
- In the last couple of years the Operating Margin of TCMD has grown nicely.
- TCMD has a Gross Margin of 49.88%. This is comparable to the rest of the industry: TCMD outperforms 44.62% of its industry peers.
- TCMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.39% | ||
| PM (TTM) | 5.83% | ||
| GM | 49.88% |
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TCMD is destroying value.
- Compared to 1 year ago, TCMD has more shares outstanding
- The number of shares outstanding for TCMD has been increased compared to 5 years ago.
- Compared to 1 year ago, TCMD has an improved debt to assets ratio.
2.2 Solvency
- TCMD has an Altman-Z score of 9.05. This indicates that TCMD is financially healthy and has little risk of bankruptcy at the moment.
- TCMD's Altman-Z score of 9.05 is amongst the best of the industry. TCMD outperforms 87.63% of its industry peers.
- TCMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 9.05 |
ROIC/WACC0.77
WACC9.81%
2.3 Liquidity
- A Current Ratio of 3.61 indicates that TCMD has no problem at all paying its short term obligations.
- With a decent Current ratio value of 3.61, TCMD is doing good in the industry, outperforming 62.90% of the companies in the same industry.
- A Quick Ratio of 3.20 indicates that TCMD has no problem at all paying its short term obligations.
- TCMD's Quick ratio of 3.20 is fine compared to the rest of the industry. TCMD outperforms 67.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.2 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 16.67% over the past year.
- The Earnings Per Share has been growing slightly by 4.86% on average over the past years.
- Looking at the last year, TCMD shows a quite strong growth in Revenue. The Revenue has grown by 9.28% in the last year.
- TCMD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.11% yearly.
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
Revenue 1Y (TTM)9.28%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.32%
3.2 Future
- The Earnings Per Share is expected to grow by 20.90% on average over the next years. This is a very strong growth
- The Revenue is expected to grow by 8.94% on average over the next years. This is quite good.
EPS Next Y14.93%
EPS Next 2Y19.86%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue Next Year9.19%
Revenue Next 2Y9.01%
Revenue Next 3Y8.94%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 35.87, the valuation of TCMD can be described as expensive.
- Based on the Price/Earnings ratio, TCMD is valued a bit cheaper than 72.58% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 28.23, TCMD is valued a bit more expensive.
- A Price/Forward Earnings ratio of 27.08 indicates a quite expensive valuation of TCMD.
- 72.58% of the companies in the same industry are more expensive than TCMD, based on the Price/Forward Earnings ratio.
- TCMD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.01, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.87 | ||
| Fwd PE | 27.08 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TCMD indicates a somewhat cheap valuation: TCMD is cheaper than 79.57% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, TCMD is valued cheaper than 94.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.66 | ||
| EV/EBITDA | 17.56 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- TCMD has a very decent profitability rating, which may justify a higher PE ratio.
- TCMD's earnings are expected to grow with 20.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.4
PEG (5Y)7.38
EPS Next 2Y19.86%
EPS Next 3Y20.9%
5. Dividend
5.1 Amount
- No dividends for TCMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
27.62
-0.05 (-0.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-03 2025-11-03/amc
Earnings (Next)02-17 2026-02-17/amc
Inst Owners99.01%
Inst Owner Change-2.56%
Ins Owners2.66%
Ins Owner Change-0.31%
Market Cap617.03M
Revenue(TTM)311.51M
Net Income(TTM)18.17M
Analysts81.82
Price Target30.35 (9.88%)
Short Float %8.55%
Short Ratio5.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.96%
Min EPS beat(2)27.09%
Max EPS beat(2)102.84%
EPS beat(4)3
Avg EPS beat(4)18.21%
Min EPS beat(4)-82.07%
Max EPS beat(4)102.84%
EPS beat(8)7
Avg EPS beat(8)30.85%
EPS beat(12)11
Avg EPS beat(12)304.86%
EPS beat(16)11
Avg EPS beat(16)169.54%
Revenue beat(2)2
Avg Revenue beat(2)5.32%
Min Revenue beat(2)4.63%
Max Revenue beat(2)6.01%
Revenue beat(4)2
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-5.08%
Max Revenue beat(4)6.01%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)6
Avg Revenue beat(12)0.51%
Revenue beat(16)10
Avg Revenue beat(16)1.53%
PT rev (1m)23.96%
PT rev (3m)76.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.92%
EPS NY rev (1m)0.25%
EPS NY rev (3m)29.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.87 | ||
| Fwd PE | 27.08 | ||
| P/S | 1.98 | ||
| P/FCF | 15.66 | ||
| P/OCF | 14.74 | ||
| P/B | 3.01 | ||
| P/tB | 4.61 | ||
| EV/EBITDA | 17.56 |
EPS(TTM)0.77
EY2.79%
EPS(NY)1.02
Fwd EY3.69%
FCF(TTM)1.76
FCFY6.39%
OCF(TTM)1.87
OCFY6.78%
SpS13.94
BVpS9.17
TBVpS5.99
PEG (NY)2.4
PEG (5Y)7.38
Graham Number12.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.01% | ||
| ROE | 8.86% | ||
| ROCE | 10.46% | ||
| ROIC | 7.56% | ||
| ROICexc | 11.94% | ||
| ROICexgc | 24.41% | ||
| OM | 7.39% | ||
| PM (TTM) | 5.83% | ||
| GM | 49.88% | ||
| FCFM | 12.65% |
ROA(3y)2.94%
ROA(5y)0.73%
ROE(3y)2.6%
ROE(5y)-0.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y15.26%
ROICexc growth 3YN/A
ROICexc growth 5Y1.86%
OM growth 3YN/A
OM growth 5Y6.44%
PM growth 3YN/A
PM growth 5Y-0.06%
GM growth 3Y3.35%
GM growth 5Y-0.43%
F-Score7
Asset Turnover1.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 36.37% | ||
| Cap/Sales | 0.79% | ||
| Interest Coverage | 17.31 | ||
| Cash Conversion | 140.64% | ||
| Profit Quality | 216.85% | ||
| Current Ratio | 3.61 | ||
| Quick Ratio | 3.2 | ||
| Altman-Z | 9.05 |
F-Score7
WACC9.81%
ROIC/WACC0.77
Cap/Depr(3y)35.17%
Cap/Depr(5y)50.34%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5Y4.86%
EPS Q2Q%71.43%
EPS Next Y14.93%
EPS Next 2Y19.86%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue 1Y (TTM)9.28%
Revenue growth 3Y12.08%
Revenue growth 5Y9.11%
Sales Q2Q%17.32%
Revenue Next Year9.19%
Revenue Next 2Y9.01%
Revenue Next 3Y8.94%
Revenue Next 5YN/A
EBIT growth 1Y7.23%
EBIT growth 3YN/A
EBIT growth 5Y16.13%
EBIT Next Year85.47%
EBIT Next 3Y35.54%
EBIT Next 5YN/A
FCF growth 1Y99.58%
FCF growth 3Y420.83%
FCF growth 5YN/A
OCF growth 1Y95.92%
OCF growth 3Y149.11%
OCF growth 5Y74.54%
TACTILE SYSTEMS TECHNOLOGY I / TCMD FAQ
Can you provide the ChartMill fundamental rating for TACTILE SYSTEMS TECHNOLOGY I?
ChartMill assigns a fundamental rating of 6 / 10 to TCMD.
What is the valuation status of TACTILE SYSTEMS TECHNOLOGY I (TCMD) stock?
ChartMill assigns a valuation rating of 5 / 10 to TACTILE SYSTEMS TECHNOLOGY I (TCMD). This can be considered as Fairly Valued.
What is the profitability of TCMD stock?
TACTILE SYSTEMS TECHNOLOGY I (TCMD) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for TCMD stock?
The Price/Earnings (PE) ratio for TACTILE SYSTEMS TECHNOLOGY I (TCMD) is 35.87 and the Price/Book (PB) ratio is 3.01.
What is the expected EPS growth for TACTILE SYSTEMS TECHNOLOGY I (TCMD) stock?
The Earnings per Share (EPS) of TACTILE SYSTEMS TECHNOLOGY I (TCMD) is expected to grow by 14.93% in the next year.